about
Autism and Metabolic DiseasesThe cataract and glucosuria associated monocarboxylate transporter MCT12 is a new creatine transporterHigh prevalence of SLC6A8 deficiency in X-linked mental retardationCreatine synthesis and transport during rat embryogenesis: spatiotemporal expression of AGAT, GAMT and CT1.The effect of the creatine analogue beta-guanidinopropionic acid on energy metabolism: a systematic reviewCreatine transporter (CrT; Slc6a8) knockout mice as a model of human CrT deficiencyDiagnostic methods and recommendations for the cerebral creatine deficiency syndromes.X-linked creatine transporter defect: a report on two unrelated boys with a severe clinical phenotype.Comparison of time-dependent effects of (+)-methamphetamine or forced swim on monoamines, corticosterone, glucose, creatine, and creatinine in ratsShould metabolic diseases be systematically screened in nonsyndromic autism spectrum disorders?Therapeutic use of creatine in brain or heart ischemia: available data and future perspectives.Substituted cysteine accessibility of the third transmembrane domain of the creatine transporter: defining a transport pathway.Autism-lessons from the X chromosome.Creatine supplementation associated or not with strength training upon emotional and cognitive measures in older women: a randomized double-blind studyNeuropsychological profile and clinical effects of arginine treatment in children with creatine transport deficiency.Screening for primary creatine deficiencies in French patients with unexplained neurological symptomsMutation screening of the ARX gene in patients with autismCreatine Transporter Deficiency: Screening of Males with Neurodevelopmental Disorders and Neurocognitive Characterization of a Case.Creatine transporter deficiency in two adult patients with static encephalopathy.A Japanese adult case of guanidinoacetate methyltransferase deficiency.In sickness and in health: the widespread application of creatine supplementation.X-linked creatine transporter deficiency: clinical aspects and pathophysiology.Solute Carriers in the Blood-Brain Barier: Safety in Abundance.Effects of N-linked glycosylation on the creatine transporter.Creatine transporter deficiency: Novel mutations and functional studies.Altered carbon dioxide metabolism and creatine abnormalities in rett syndrome.Quantification of creatine and guanidinoacetate using GC-MS and LC-MS/MS for the detection of cerebral creatine deficiency syndromes.X-linked creatine transporter deficiency presenting as a mitochondrial disorder.Effects of amide creatine derivatives in brain hippocampal slices, and their possible usefulness for curing creatine transporter deficiency.Curcumin ameliorates diclofenac sodium-induced nephrotoxicity in male albino rats.Creatine transporter localization in developing and adult retina: importance of creatine to retinal function.Cell-Type-Specific Spatiotemporal Expression of Creatine Biosynthetic Enzyme S-adenosylmethionine:guanidinoacetate N-methyltransferase in Developing Mouse Brain.Does brain creatine content rely on exogenous creatine in healthy youth? A proof-of-principle study.Distribution of the creatine transporter throughout the human brain reveals a spectrum of creatine transporter immunoreactivity.Downregulation of the creatine transporter SLC6A8 by JAK2.Expression and distribution of creatine transporter and creatine kinase (brain isoform) in developing and mature rat cochlear tissues.Brain creatine depletion in vegetarians? A cross-sectional ¹H-magnetic resonance spectroscopy (¹H-MRS) study.Creatine transport across the plasma membraneDisorders of creatine transport and metabolism.Phenotype and genotype in 101 males with X-linked creatine transporter deficiency.
P2860
Q22241822-DB743D00-AB5B-41EB-AEC9-796B435F96F4Q24338344-237ADE9C-107E-4D4B-B439-5291201895B4Q24533559-22EFA4B8-D372-49E2-91E4-8FC6CFA290C1Q24811264-6C72E6B6-F363-4E9B-95F2-5442E5906FD2Q26822632-0520C91A-3680-40E7-B7D0-B8F399AA4BD6Q30477551-8A0748F3-A369-4D4C-AB23-9C2E41766BD1Q30880728-715142DE-0188-453A-B6B9-3B5418CD30F2Q31036314-C2E51632-B31E-4526-ABC5-93CBA35DDC5FQ33339006-73CFBB56-2048-402A-B330-0C2757F7A0E1Q33961594-03F017CB-A0BD-42EC-AD46-7BDA154D289DQ34089086-FDBBEAF6-11ED-469D-A215-57D2AC472004Q34437605-6B28613D-A683-4AB0-B578-DE9E724290ACQ34872860-D93FFE5E-E6B0-4B54-A908-60622FF45EA7Q35009362-B6674401-16D5-4BF9-9358-21837A16B4FBQ36478674-BD25E159-B6E6-485D-828C-79A5301524E8Q36556209-ED023C4E-EEDB-44CF-8405-85E12BA888E9Q36783161-4BEF13F7-6346-4012-82DF-8E66660CE962Q37002978-646A4F4C-54F0-4716-8723-9398D2BDFDD3Q37423172-E931E52A-9839-4FF5-AF9C-CBA8A0DA0E9BQ37500634-61705564-4A02-4B83-A066-D155BF384802Q37958749-9D165DE8-42DA-4FE6-A0C6-D2BC4021F19CQ38208767-1F163E53-95B2-4795-8FEF-CDA02D6DEB83Q38922312-EF0C40B7-B34B-4E1D-9B25-1DA1961B619EQ40372477-FACA48A7-9C3F-456B-9597-B8EF557624E0Q41923519-CA34AC1A-3F6F-4B23-8646-B2D8A91C5473Q42151904-7AB36671-19B8-441F-88EF-F0DB76A44035Q42167858-CC874D4E-6A56-4D57-B881-861FF4AF1FE1Q43054521-F536849D-AC2F-44A8-BD1F-9C57AD8754F0Q46008287-E2A8DF1C-1861-466A-926A-B0B7F19629DDQ46240031-9317DB3D-AACF-4D4C-BBAD-85C6AEFEC310Q46522477-5EDC8507-EDB4-428E-A2BE-46C71DE733BEQ47930663-5BF954A9-0371-4C77-9D8D-8348FF22209FQ48361280-8DCE482E-F073-48D9-AB80-065B9F4530DEQ48583660-C51B9FC2-F8AE-4BF7-8D26-DFEF9D93F0CDQ48653545-33531245-F915-47DD-82DD-0EBA992D75E9Q48673078-5A4B119B-FE4D-42A6-BCD2-BF51E0097C67Q48832841-2A341E68-AEED-4B5D-9B14-CCB54A504432Q50295095-C4729D81-DB1E-43B1-933D-506BA102BA2EQ50312835-E53FE8A6-65A8-4DB7-A426-C9E6D8BCEC15Q50711007-454842A8-2464-421C-A96A-514BCDAAB4CA
P2860
description
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2003
@ast
im Januar 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2003/01/01)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/01/01)
@nl
наукова стаття, опублікована в січні 2003
@uk
مقالة علمية (نشرت عام 2003)
@ar
name
X-linked creatine transporter defect: an overview
@ast
X-linked creatine transporter defect: an overview
@en
X-linked creatine transporter defect: an overview
@nl
type
label
X-linked creatine transporter defect: an overview
@ast
X-linked creatine transporter defect: an overview
@en
X-linked creatine transporter defect: an overview
@nl
prefLabel
X-linked creatine transporter defect: an overview
@ast
X-linked creatine transporter defect: an overview
@en
X-linked creatine transporter defect: an overview
@nl
P2093
P3181
P356
P1476
X-linked creatine transporter defect: an overview
@en
P2093
C. Schwartz
D. Marsden
G. S. Salomons
K. M. Cecil
N. M. Verhoeven
S. J. M. van Dooren
T. J. DeGrauw
P2888
P304
P3181
P356
10.1023/A:1024405821638
P577
2003-01-01T00:00:00Z
P6179
1052949777